Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
MousePheno	failure of somite differentiation	FN1 PDGFRA RIPPLY2 CUBN FGFR1 RAC1	4.70e-07	50	83	6	MP:0001690
MousePheno	impaired somite development	FN1 PDGFRA RIPPLY2 CUBN FGFR1 RAC1	3.48e-05	104	83	6	MP:0009768
MousePheno	abnormal somite development	FN1 PDGFRA RIPPLY2 CUBN CTBP2 FGFR1 FOXH1 RAC1	5.06e-05	222	83	8	MP:0001688
Domain	Runt	RUNX2 RUNX1	8.15e-05	3	98	2	PF00853
Domain	RUNT	RUNX2 RUNX1	8.15e-05	3	98	2	PS51062
Domain	TF_Runt-rel_RUNX	RUNX2 RUNX1	8.15e-05	3	98	2	IPR016554
Domain	RunxI	RUNX2 RUNX1	8.15e-05	3	98	2	PF08504
Domain	Runt_dom	RUNX2 RUNX1	8.15e-05	3	98	2	IPR013524
Domain	RunxI_C_dom	RUNX2 RUNX1	8.15e-05	3	98	2	IPR013711
Domain	Runx_central_dom	RUNX2 RUNX1	8.15e-05	3	98	2	IPR027384
Domain	-	RUNX2 RUNX1	8.15e-05	3	98	2	4.10.770.10
Domain	AML1_Runt	RUNX2 RUNX1	8.15e-05	3	98	2	IPR000040
Domain	Tyr_kinase_cat_dom	PDGFRA BMX CSF1R TNK2 FGFR1	9.96e-05	88	98	5	IPR020635
Domain	TyrKc	PDGFRA BMX CSF1R TNK2 FGFR1	9.96e-05	88	98	5	SM00219
Domain	PROTEIN_KINASE_TYR	PDGFRA BMX CSF1R TNK2 FGFR1	1.58e-04	97	98	5	PS00109
Domain	Tyr_kinase_AS	PDGFRA BMX CSF1R TNK2 FGFR1	1.58e-04	97	98	5	IPR008266
Domain	FAM86	FAM86B1 FAM86B2	1.62e-04	4	98	2	IPR029426
Domain	FAM86	FAM86B1 FAM86B2	1.62e-04	4	98	2	PF14904
Domain	TRYPSIN_HIS	PRSS35 TMPRSS15 F2 GZMB TMPRSS7	2.09e-04	103	98	5	IPR018114
Domain	TRYPSIN_SER	PRSS35 TMPRSS15 F2 GZMB TMPRSS7	2.39e-04	106	98	5	PS00135
Domain	TRYPSIN_HIS	PRSS35 TMPRSS15 F2 GZMB TMPRSS7	2.50e-04	107	98	5	PS00134
Domain	Ig-like_fold	SEMA4B PRTG FN1 PDGFRA CD300A FNDC3A CSF1R LINGO1 FGFR1 IL5RA MOG IGSF3	3.21e-04	706	98	12	IPR013783
Domain	TRYPSIN_DOM	PRSS35 TMPRSS15 F2 GZMB TMPRSS7	3.49e-04	115	98	5	PS50240
Domain	Tryp_SPc	PRSS35 TMPRSS15 F2 GZMB TMPRSS7	3.78e-04	117	98	5	SM00020
Domain	p53/RUNT-type_TF_DNA-bd	RUNX2 RUNX1	4.03e-04	6	98	2	IPR012346
Domain	-	RUNX2 RUNX1	4.03e-04	6	98	2	2.60.40.720
Domain	Tyr_kinase_CSF1/PDGF_rcpt	PDGFRA CSF1R	4.03e-04	6	98	2	IPR016243
Domain	-	CARM1 FAM86B1 FAM86B2 BCDIN3D NSUN7	4.25e-04	120	98	5	3.40.50.150
Domain	Trypsin_dom	PRSS35 TMPRSS15 F2 GZMB TMPRSS7	4.41e-04	121	98	5	IPR001254
Domain	Trypsin	PRSS35 TMPRSS15 F2 GZMB TMPRSS7	4.41e-04	121	98	5	PF00089
Domain	SAM-dependent_MTases	CARM1 FAM86B1 FAM86B2 BCDIN3D NSUN7	4.58e-04	122	98	5	IPR029063
Domain	Peptidase_S1_PA	PRSS35 TMPRSS15 F2 GZMB TMPRSS7	4.76e-04	123	98	5	IPR009003
Domain	Pkinase_Tyr	PDGFRA BMX CSF1R TNK2 FGFR1	5.91e-04	129	98	5	PF07714
Domain	-	PRTG FN1 PDGFRA CD300A FNDC3A CSF1R LINGO1 FGFR1 IL5RA MOG IGSF3	7.06e-04	663	98	11	2.60.40.10
Domain	Tyr_kinase_rcpt_3_CS	PDGFRA CSF1R	7.48e-04	8	98	2	IPR001824
Domain	RECEPTOR_TYR_KIN_III	PDGFRA CSF1R	7.48e-04	8	98	2	PS00240
Domain	Ser-Thr/Tyr_kinase_cat_dom	PDGFRA BMX CSF1R TNK2 FGFR1	8.02e-04	138	98	5	IPR001245
Domain	LDLR_class-A_CS	TMPRSS15 MALRD1 TMPRSS7	1.20e-03	40	98	3	IPR023415
Domain	TRYPSIN_SER	TMPRSS15 F2 GZMB TMPRSS7	1.29e-03	90	98	4	IPR033116
Domain	Methyltransf_16	FAM86B1 FAM86B2	1.45e-03	11	98	2	IPR019410
Domain	Methyltransf_16	FAM86B1 FAM86B2	1.45e-03	11	98	2	PF10294
Domain	IGc2	PRTG PDGFRA CSF1R LINGO1 FGFR1 IGSF3	1.50e-03	235	98	6	SM00408
Domain	Ig_sub2	PRTG PDGFRA CSF1R LINGO1 FGFR1 IGSF3	1.50e-03	235	98	6	IPR003598
Domain	IG	PRTG PDGFRA CD300A CSF1R LINGO1 FGFR1 MOG IGSF3	1.68e-03	421	98	8	SM00409
Domain	Ig_sub	PRTG PDGFRA CD300A CSF1R LINGO1 FGFR1 MOG IGSF3	1.68e-03	421	98	8	IPR003599
Domain	Ldl_recept_a	TMPRSS15 MALRD1 TMPRSS7	1.69e-03	45	98	3	PF00057
Domain	-	TMPRSS15 MALRD1 TMPRSS7	1.81e-03	46	98	3	4.10.400.10
Domain	LDLRA_1	TMPRSS15 MALRD1 TMPRSS7	2.04e-03	48	98	3	PS01209
Domain	CUB	TMPRSS15 CUBN TMPRSS7	2.17e-03	49	98	3	PF00431
Domain	LDrepeatLR_classA_rpt	TMPRSS15 MALRD1 TMPRSS7	2.17e-03	49	98	3	IPR002172
Domain	LDLa	TMPRSS15 MALRD1 TMPRSS7	2.17e-03	49	98	3	SM00192
Domain	LDLRA_2	TMPRSS15 MALRD1 TMPRSS7	2.17e-03	49	98	3	PS50068
Domain	CUB	TMPRSS15 CUBN TMPRSS7	2.30e-03	50	98	3	SM00042
Domain	-	TMPRSS15 CUBN TMPRSS7	2.57e-03	52	98	3	2.60.120.290
Domain	CUB	TMPRSS15 CUBN TMPRSS7	2.71e-03	53	98	3	PS01180
Domain	-	TMPRSS15 TMPRSS7	2.74e-03	15	98	2	3.30.70.960
Domain	Peptidase_S1A	TMPRSS15 F2 GZMB TMPRSS7	2.97e-03	113	98	4	IPR001314
Domain	CUB_dom	TMPRSS15 CUBN TMPRSS7	3.34e-03	57	98	3	IPR000859
Domain	MAM	TMPRSS15 MALRD1	3.52e-03	17	98	2	SM00137
Domain	MAM	TMPRSS15 MALRD1	3.95e-03	18	98	2	PF00629
Domain	MAM_dom	TMPRSS15 MALRD1	3.95e-03	18	98	2	IPR000998
Domain	MAM_2	TMPRSS15 MALRD1	3.95e-03	18	98	2	PS50060
Domain	IG_LIKE	PRTG PDGFRA CD300A CSF1R LINGO1 FGFR1 MOG IGSF3	4.30e-03	491	98	8	PS50835
Domain	Ig-like_dom	PRTG PDGFRA CD300A CSF1R LINGO1 FGFR1 MOG IGSF3	4.96e-03	503	98	8	IPR007110
Pathway	PID_SYNDECAN_4_PATHWAY	FN1 F2 FGFR1 RAC1	1.91e-05	32	71	4	M165
Pathway	WP_CANCER_PATHWAYS	FN1 PDGFRA ESR2 RUNX1 F2 CSF1R CCNE2 CTBP2 FGFR1 IL5RA RAC1	4.24e-05	507	71	11	M48302
Pathway	PID_ANGIOPOIETIN_RECEPTOR_PATHWAY	FN1 F2 BMX RAC1	1.05e-04	49	71	4	M92
Pubmed	The protein tyrosine kinase family of the human genome.	PDGFRA BMX CSF1R TNK2 FGFR1	5.24e-06	83	104	5	11114734
Pubmed	Receptor tyrosine kinases modulate distinct transcriptional programs by differential usage of intracellular pathways.	PDGFRA RUNX2 FGFR1	5.60e-06	12	104	3	25951516
Pubmed	The cDNA cloning of the transcripts of human PEBP2alphaA/CBFA1 mapped to 6p12.3-p21.1, the locus for cleidocranial dysplasia.	RUNX2 RUNX1	8.86e-06	2	104	2	9233771
Pubmed	Dual Targeting of PDGFRα and FGFR1 Displays Synergistic Efficacy in Malignant Rhabdoid Tumors.	PDGFRA FGFR1	8.86e-06	2	104	2	27783942
Pubmed	FGF signaling is required for myofibroblast differentiation during alveolar regeneration.	PDGFRA FGFR1	8.86e-06	2	104	2	19502291
Pubmed	CARM1 promotes non-small cell lung cancer progression through upregulating CCNE2 expression.	CARM1 CCNE2	8.86e-06	2	104	2	32487779
Pubmed	Fibroblast growth factor 1 (FGFR1) modulation regulates repair capacity of oligodendrocyte progenitor cells following chronic demyelination.	PDGFRA FGFR1	8.86e-06	2	104	2	21854849
Pubmed	Prognostic relevance of RIP140 and ERβ expression in unifocal versus multifocal breast cancers: a preliminary report.	NRIP1 ESR2	8.86e-06	2	104	2	30669416
Pubmed	Runx1/AML1/Cbfa2 mediates onset of mesenchymal cell differentiation toward chondrogenesis.	RUNX2 RUNX1	8.86e-06	2	104	2	16059634
Pubmed	Knockdown of receptor interacting protein 140 (RIP140) alleviated lipopolysaccharide-induced inflammation, apoptosis and permeability in pulmonary microvascular endothelial cells by regulating C-terminal binding protein 2 (CTBP2).	NRIP1 CTBP2	8.86e-06	2	104	2	35113002
Pubmed	RUNX1 and RUNX2 transcription factors function in opposing roles to regulate breast cancer stem cells.	RUNX2 RUNX1	8.86e-06	2	104	2	32180230
Pubmed	Sequence survey of receptor tyrosine kinases reveals mutations in glioblastomas.	PDGFRA FGFR1	8.86e-06	2	104	2	16186508
Pubmed	Disease mutations in RUNX1 and RUNX2 create nonfunctional, dominant-negative, or hypomorphic alleles.	RUNX2 RUNX1	8.86e-06	2	104	2	17290219
Pubmed	Nonsense mutation of the stereociliar membrane protein gene PTPRQ in human hearing loss DFNB84.	OTOGL PTPRQ	8.86e-06	2	104	2	20472657
Pubmed	Identification of a novel FN1-FGFR1 genetic fusion as a frequent event in phosphaturic mesenchymal tumour.	FN1 FGFR1	8.86e-06	2	104	2	25319834
Pubmed	Fibrotic enzymes modulate wound-induced skin tumorigenesis.	PRSS35 PDGFRA	8.86e-06	2	104	2	33780134
Pubmed	Novel insights into a retinoic-acid-induced cleft palate based on Rac1 regulation of the fibronectin arrangement.	FN1 RAC1	8.86e-06	2	104	2	26329303
Pubmed	Runx1 and Runx2 inhibit fibrotic conversion of cellular niches for hematopoietic stem cells.	RUNX2 RUNX1	8.86e-06	2	104	2	35551452
Pubmed	Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemia.	RUNX2 RUNX1	8.86e-06	2	104	2	23321257
Pubmed	Expression of AML/Runx and ETO/MTG family members during hematopoietic differentiation of embryonic stem cells.	RUNX2 RUNX1	8.86e-06	2	104	2	17533052
Pubmed	Negative regulation of estrogen signaling by ERβ and RIP140 in ovarian cancer cells.	NRIP1 ESR2	8.86e-06	2	104	2	23885094
Pubmed	A microRNA/Runx1/Runx2 network regulates prostate tumor progression from onset to adenocarcinoma in TRAMP mice.	RUNX2 RUNX1	8.86e-06	2	104	2	27634876
Pubmed	Role of Rac 1 and cAMP in endothelial barrier stabilization and thrombin-induced barrier breakdown.	F2 RAC1	8.86e-06	2	104	2	19472214
Pubmed	Identification and expression of a novel 3'-exon of mouse Runx1/Pebp2alphaB/Cbfa2/AML1 gene.	RUNX2 RUNX1	8.86e-06	2	104	2	10903914
Pubmed	Expression of the immunoglobulin superfamily cell adhesion molecules in the developing spinal cord and dorsal root ganglion.	SEMA4B PRTG CD300A CSF1R LINGO1 IGSF3	9.69e-06	162	104	6	25826454
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	GPHN NEMP1 CHAF1A FRMPD1 LARS1 MDN1 CTBP2 FOXH1 SNX9 SF3B2 RAC1 XPO7	1.01e-05	857	104	12	25609649
Pubmed	Head bobber: an insertional mutation causes inner ear defects, hyperactive circling, and deafness.	FN1 CPXM2 CTBP2	1.15e-05	15	104	3	22383091
Pubmed	Co-activator activator (CoAA) prevents the transcriptional activity of Runt domain transcription factors.	RUNX2 RUNX1	2.65e-05	3	104	2	19585539
Pubmed	Epigenetic consequences of AML1-ETO action at the human c-FMS locus.	RUNX1 CSF1R	2.65e-05	3	104	2	12773394
Pubmed	A molecular atlas of cell types and zonation in the brain vasculature.	PDGFRA BMX	2.65e-05	3	104	2	29443965
Pubmed	Expression of Runx1, -2 and -3 during tooth, palate and craniofacial bone development.	RUNX2 RUNX1	2.65e-05	3	104	2	14516670
Pubmed	Enforced expression of Runx2 perturbs T cell development at a stage coincident with beta-selection.	RUNX2 RUNX1	2.65e-05	3	104	2	12218099
Pubmed	Characterization of four autonomous repression domains in the corepressor receptor interacting protein 140.	NRIP1 CTBP2	2.65e-05	3	104	2	14736873
Pubmed	Spatiotemporal signaling underlies progressive vascular rarefaction in myocardial infarction.	HIC1 PDGFRA	2.65e-05	3	104	2	38129410
Pubmed	A multigenic combination of estrogen related genes are associated with the duration of fertility period in the Spanish population.	NRIP1 ESR2	2.65e-05	3	104	2	23173577
Pubmed	The Cdc42 target ACK2 interacts with sorting nexin 9 (SH3PX1) to regulate epidermal growth factor receptor degradation.	TNK2 SNX9	2.65e-05	3	104	2	11799118
Pubmed	The Rho GTPase RAC1 in Osteoblasts Controls Their Function.	RUNX2 RAC1	2.65e-05	3	104	2	31936261
Pubmed	Activation of Rac1 by Src-dependent phosphorylation of Dock180(Y1811) mediates PDGFRα-stimulated glioma tumorigenesis in mice and humans.	PDGFRA RAC1	2.65e-05	3	104	2	22080864
Pubmed	RUNX1 (AML-1) and RUNX2 (AML-3) cooperate with prostate-derived Ets factor to activate transcription from the PSA upstream regulatory region.	RUNX2 RUNX1	2.65e-05	3	104	2	16237704
Pubmed	Positional Stability and Membrane Occupancy Define Skin Fibroblast Homeostasis In Vivo.	PDGFRA RAC1	2.65e-05	3	104	2	30415836
Pubmed	AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization.	RUNX2 RUNX1	2.65e-05	3	104	2	7835892
Pubmed	Platelet-derived growth factor receptor-α and Ras-related C3 botulinum toxin substrate-1 regulate mechano-responsiveness of lung fibroblasts.	PDGFRA RAC1	2.65e-05	3	104	2	28775097
Pubmed	BMX Represses Thrombin-PAR1-Mediated Endothelial Permeability and Vascular Leakage During Early Sepsis.	F2 BMX	2.65e-05	3	104	2	31910739
Pubmed	Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor.	RUNX2 RUNX1	2.65e-05	3	104	2	8497254
Pubmed	AML3/CBFalpha1 is required for androgen-specific activation of the enhancer of the mouse sex-limited protein (Slp) gene.	RUNX2 RUNX1	2.65e-05	3	104	2	10521447
Pubmed	Dimerization is required for SH3PX1 tyrosine phosphorylation in response to epidermal growth factor signalling and interaction with ACK2.	TNK2 SNX9	2.65e-05	3	104	2	16316319
Pubmed	Signaling-mediated cooperativity between glycoprotein Ib-IX and protease-activated receptors in thrombin-induced platelet activation.	F2 RAC1	2.65e-05	3	104	2	26585954
Pubmed	PIKfyve, MTMR3 and their product PtdIns5P regulate cancer cell migration and invasion through activation of Rac1.	PIKFYVE RAC1	2.65e-05	3	104	2	24840251
Pubmed	A L225A substitution in the human tumour suppressor HIC1 abolishes its interaction with the corepressor CtBP.	HIC1 CTBP2	2.65e-05	3	104	2	16762039
Pubmed	Core Binding Factor β Expression in Ovarian Granulosa Cells Is Essential for Female Fertility.	ESR2 RUNX2	2.65e-05	3	104	2	29554271
Pubmed	Core Binding Factors are essential for ovulation, luteinization, and female fertility in mice.	ESR2 RUNX2	2.65e-05	3	104	2	32555437
Pubmed	Thrombin induces NF-kappaB activation and IL-8/CXCL8 expression in lung epithelial cells by a Rac1-dependent PI3K/Akt pathway.	F2 RAC1	2.65e-05	3	104	2	21266580
Pubmed	Co-active receptor tyrosine kinases mitigate the effect of FGFR inhibitors in FGFR1-amplified lung cancers with low FGFR1 protein expression.	PDGFRA FGFR1	2.65e-05	3	104	2	26549034
Pubmed	The murine myeloperoxidase promoter contains several functional elements, one of which binds a cell type-restricted transcription factor, myeloid nuclear factor 1 (MyNF1).	RUNX2 RUNX1	2.65e-05	3	104	2	8384306
Pubmed	The RUNX1 Runt domain at 1.25A resolution: a structural switch and specifically bound chloride ions modulate DNA binding.	RUNX2 RUNX1	2.65e-05	3	104	2	12217689
Pubmed	Mesenchymal stromal cells: inhibiting PDGF receptors or depleting fibronectin induces mesodermal progenitors with endothelial potential.	FN1 PDGFRA	2.65e-05	3	104	2	24022915
Pubmed	Basic fibroblast growth factor in the bone microenvironment enhances cell motility and invasion of Ewing's sarcoma family of tumours by activating the FGFR1-PI3K-Rac1 pathway.	FGFR1 RAC1	2.65e-05	3	104	2	20606682
Pubmed	Novel cleft susceptibility genes in chromosome 6q.	PRSS35 RIPPLY2	2.65e-05	3	104	2	20511563
Pubmed	Shared and distinct roles mediated through C-terminal subdomains of acute myeloid leukemia/Runt-related transcription factor molecules in murine development.	RUNX2 RUNX1	2.65e-05	3	104	2	15713794
Pubmed	Metastatic breast cancer cells inhibit osteoblast differentiation through the Runx2/CBFβ-dependent expression of the Wnt antagonist, sclerostin.	RUNX2 RUNX1	2.65e-05	3	104	2	22032690
Pubmed	Genetic regulation of the RUNX transcription factor family has antitumor effects.	RUNX2 RUNX1	2.65e-05	3	104	2	28530640
Pubmed	Early chromatin unfolding by RUNX1: a molecular explanation for differential requirements during specification versus maintenance of the hematopoietic gene expression program.	RUNX1 CSF1R	2.65e-05	3	104	2	19339695
Pubmed	FNDC5/irisin facilitates muscle-adipose-bone connectivity through ubiquitination-dependent activation of runt-related transcriptional factors RUNX1/2.	RUNX2 RUNX1	2.65e-05	3	104	2	35124008
Pubmed	Regulation of tissue inhibitor of metalloproteinase 1 gene transcription by RUNX1 and RUNX2.	RUNX2 RUNX1	2.65e-05	3	104	2	15051730
Pubmed	Identification and comparative analysis of a second runx3 promoter.	RUNX2 RUNX1	2.65e-05	3	104	2	11483356
Pubmed	PEBP2/CBF, the murine homolog of the human myeloid AML1 and PEBP2 beta/CBF beta proto-oncoproteins, regulates the murine myeloperoxidase and neutrophil elastase genes in immature myeloid cells.	RUNX2 RUNX1	2.65e-05	3	104	2	8035830
Pubmed	Activated cdc42-associated kinase is up-regulated in non-small-cell lung cancer and necessary for FGFR-mediated AKT activation.	TNK2 FGFR1	2.65e-05	3	104	2	25945695
Pubmed	RUNX1 and RUNX2 upregulate Galectin-3 expression in human pituitary tumors.	RUNX2 RUNX1	2.65e-05	3	104	2	19020999
Pubmed	Regulation of cell surface protease matriptase by HAI2 is essential for placental development, neural tube closure and embryonic survival in mice.	F2 GZMB TMPRSS7	3.32e-05	21	104	3	19592578
Pubmed	AML1(-/-) embryos do not express certain hematopoiesis-related gene transcripts including those of the PU.1 gene.	RUNX2 RUNX1 CSF1R	3.84e-05	22	104	3	9811459
Pubmed	Epicardial function of canonical Wnt-, Hedgehog-, Fgfr1/2-, and Pdgfra-signalling.	FN1 PDGFRA FGFR1	3.84e-05	22	104	3	24000064
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	CARM1 SEMA4B MBTPS1 ZNF486 PDGFRA UFC1 CHAF1A MSL1 HSD3B7 UBE2J2 INTS2 MCM3AP PTAR1 CPSF1	4.18e-05	1327	104	14	32694731
Pubmed	Runx2 mediates FGF signaling from epithelium to mesenchyme during tooth morphogenesis.	RUNX2 RUNX1 FGFR1	5.02e-05	24	104	3	15136142
Pubmed	Evolution of the interaction between Runx2 and VDR, two transcription factors involved in osteoblastogenesis.	RUNX2 RUNX1	5.29e-05	4	104	2	20236534
Pubmed	Plakoglobin regulates cell motility through Rho- and fibronectin-dependent Src signaling.	FN1 RAC1	5.29e-05	4	104	2	20876660
Pubmed	Central Role of Core Binding Factor β2 in Mucosa-Associated Lymphoid Tissue Organogenesis in Mouse.	RUNX2 RUNX1	5.29e-05	4	104	2	26001080
Pubmed	UXT interacts with the transcriptional repressor protein EVI1 and suppresses cell transformation.	RUNX1 CTBP2	5.29e-05	4	104	2	17635584
Pubmed	Microglia-organized scar-free spinal cord repair in neonatal mice.	FN1 CSF1R	5.29e-05	4	104	2	33029008
Pubmed	The Runx-PU.1 pathway preserves normal and AML/ETO9a leukemic stem cells.	RUNX2 RUNX1	5.29e-05	4	104	2	25185713
Pubmed	Physical interaction of the activator protein-1 factors c-Fos and c-Jun with Cbfa1 for collagenase-3 promoter activation.	RUNX2 RUNX1	5.29e-05	4	104	2	11641401
Pubmed	Integrative genomics of gene and metabolic regulation by estrogen receptors α and β, and their coregulators.	NRIP1 ESR2	5.29e-05	4	104	2	23774759
Pubmed	Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development.	RUNX2 RUNX1	5.29e-05	4	104	2	12464175
Pubmed	Isolation of PEBP2 alpha B cDNA representing the mouse homolog of human acute myeloid leukemia gene, AML1.	RUNX2 RUNX1	5.29e-05	4	104	2	8437866
Pubmed	Expression of RUNX2 and its signaling partners TCF7, FGFR1/2 in cleidocranial dysplasia.	RUNX2 FGFR1	5.29e-05	4	104	2	25738174
Pubmed	Inflammation-driven colon neoplasmatogenesis in uPA-deficient mice is associated with an increased expression of Runx transcriptional regulators.	RUNX2 RUNX1	5.29e-05	4	104	2	29107070
Pubmed	A WW domain-containing yes-associated protein (YAP) is a novel transcriptional co-activator.	RUNX2 RUNX1	5.29e-05	4	104	2	10228168
Pubmed	PCR-based identification of new receptors: molecular cloning of a receptor for fibroblast growth factors.	PDGFRA FGFR1	5.29e-05	4	104	2	1711190
Pubmed	Alteration on the expression of IL-1, PDGF, TGF-beta, EGF, and FGF receptors and c-Fos and c-Myc proteins in bone marrow mesenchymal stroma cells from advanced untreated lung and breast cancer patients.	PDGFRA FGFR1	5.29e-05	4	104	2	16305343
Pubmed	Hic1 Defines Quiescent Mesenchymal Progenitor Subpopulations with Distinct Functions and Fates in Skeletal Muscle Regeneration.	HIC1 PDGFRA	5.29e-05	4	104	2	31809738
Pubmed	Pathogenic Potential of Hic1-Expressing Cardiac Stromal Progenitors.	HIC1 PDGFRA	5.29e-05	4	104	2	31978365
Pubmed	Distinct mechanisms for PDGF and FGF signaling in primitive endoderm development.	PDGFRA FGFR1	5.29e-05	4	104	2	30026121
Pubmed	Molecular genetic characterization of myeloid/lymphoid neoplasms associated with eosinophilia and rearrangement of PDGFRA, PDGFRB, FGFR1 or PCM1-JAK2.	PDGFRA FGFR1	5.29e-05	4	104	2	29567772
Pubmed	Activation of β-catenin in mesenchymal progenitors leads to muscle mass loss.	HIC1 PDGFRA	5.29e-05	4	104	2	36898377
Pubmed	AP-1 and Cbfa/runt physically interact and regulate parathyroid hormone-dependent MMP13 expression in osteoblasts through a new osteoblast-specific element 2/AP-1 composite element.	RUNX2 RUNX1	5.29e-05	4	104	2	11274169
Pubmed	ALY, a context-dependent coactivator of LEF-1 and AML-1, is required for TCRalpha enhancer function.	RUNX2 RUNX1	5.29e-05	4	104	2	9119228
Pubmed	Adipocyte Piezo1 mediates obesogenic adipogenesis through the FGF1/FGFR1 signaling pathway in mice.	PDGFRA FGFR1	5.29e-05	4	104	2	32385276
Pubmed	Dual color FISH on CBF primary acute myeloid leukemia.	RUNX2 RUNX1	5.29e-05	4	104	2	20306685
Pubmed	RUNX1/ETO regulates reactive oxygen species (ROS) levels in t(8,21) acute myeloid leukaemia via FLT3 and RAC1.	RUNX1 RAC1	5.29e-05	4	104	2	37341821
Pubmed	ACK1/TNK2 tyrosine kinase: molecular signaling and evolving role in cancers.	ESR2 TNK2	5.29e-05	4	104	2	25347744
Pubmed	HIC1 interacts with a specific subunit of SWI/SNF complexes, ARID1A/BAF250A.	HIC1 CTBP2	5.29e-05	4	104	2	19486893
Cytoband	6q14.2	PRSS35 RIPPLY2	5.06e-05	5	104	2	6q14.2
GeneFamily	Receptor Tyrosine Kinases\|CD molecules	PDGFRA CSF1R FGFR1	4.55e-04	40	68	3	321
GeneFamily	Proteases, serine	PRSS35 TMPRSS15 TMPRSS7	1.72e-03	63	68	3	738
GeneFamily	Fibronectin type III domain containing	PRTG FN1 FNDC3A PTPRQ	3.10e-03	160	68	4	555
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	PRTG PDGFRA LINGO1 FGFR1	3.17e-03	161	68	4	593
GeneFamily	ADAM metallopeptidase domain containing\|CD molecules	PDGFRA CD300A CLEC7A CSF1R FGFR1 IL5RA	3.62e-03	394	68	6	471
ToppCell	mild_COVID-19_(asymptomatic)-Non-classical_Monocyte\|World / disease group, cell group and cell class (v2)	NRIP1 HIC1 CD300A RNF135 CLEC7A SFMBT2 CSF1R CTBP2	1.95e-08	195	104	8	eb809331557f8c40de45b1208cbc49b621930a4b
ToppCell	droplet-Spleen-nan-21m-Hematologic-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FN1 CD300A CLEC7A HSD3B7 FCGBP CSF1R CTBP2	1.58e-07	171	104	7	9498c35b2a2c3a339dc8c5d49c8ec20d8ad52753
ToppCell	droplet-Spleen-nan-21m-Hematologic\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FN1 CD300A CLEC7A HSD3B7 FCGBP CSF1R CTBP2	1.58e-07	171	104	7	db544252f98e073e5bb4bec4a110cd58e6434435
ToppCell	mild_COVID-19_(asymptomatic)-Non-classical_Monocyte\|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2)	NRIP1 HIC1 CD300A RNF135 SFMBT2 CSF1R CTBP2	3.58e-07	193	104	7	7839040e703877ef321494ad8926a8604729ceda
ToppCell	COVID-19_Severe-B_cell\|World / disease group, cell group and cell class	GALR1 ESR2 BMX MDN1 C12orf42 MAEL	1.38e-06	149	104	6	9a9fcbf7e8a6811958f3fd2d36315e19ab2b1127
ToppCell	droplet-Spleen-SPLEEN-1m-Hematologic\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FN1 CD300A CLEC7A HSD3B7 CSF1R CTBP2	2.98e-06	170	104	6	7cb7ad9ab064b6ea452545d145e5b1d4090cd4c1
ToppCell	droplet-Spleen-SPLEEN-1m-Hematologic-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FN1 CD300A CLEC7A HSD3B7 CSF1R CTBP2	2.98e-06	170	104	6	db7cee7e518debb2cbe9eeae05d47e14b69cb8e3
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	HIC1 CD300A CLEC7A CSF1R FCN1 ALDH4A1	5.15e-06	187	104	6	5917bdfe84cf5941e21b415aebbab3090cc5d576
ToppCell	MS-granulo1-\|MS / Condition, Cell_class and T cell subcluster	FN1 RNF135 CLEC7A CSF1R FCN1 RAC1	6.54e-06	195	104	6	eeaa2ecbcfbfb203c77261367b43ce55e786b312
ToppCell	MS-granulo1\|MS / Condition, Cell_class and T cell subcluster	FN1 RNF135 CLEC7A CSF1R FCN1 RAC1	6.54e-06	195	104	6	29688f55a6cdefbff4e818c20cb89473fbc16a59
ToppCell	10x5'v1-week_12-13-Mesenchymal_osteo-stroma\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	PRSS35 PRTG FN1 PDGFRA RUNX2 FGFR1	7.35e-06	199	104	6	d65ee89d5c7e8ed693d58e6a6de09565840e11c5
ToppCell	10x5'v1-week_12-13-Mesenchymal_osteo\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	PRSS35 PRTG FN1 PDGFRA RUNX2 FGFR1	7.35e-06	199	104	6	bf138cc692df727e087d140c014149ee5da00d9d
ToppCell	10x5'v1-week_14-16-Mesenchymal_osteo-stroma-early_osteoblast\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	PRTG FN1 PDGFRA RUNX2 SPON1 FGFR1	7.56e-06	200	104	6	16a7c398626b6e82b394eb3ef013bda3a788659d
ToppCell	proximal-mesenchymal-Adventitial_Fibroblast\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	HIC1 FN1 CPXM2 PDGFRA SPON1 FGFR1	7.56e-06	200	104	6	58c5870030192b337e7d883044948634fcd17d2c
ToppCell	proximal-mesenchymal-Adventitial_Fibroblast-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	HIC1 FN1 CPXM2 PDGFRA SPON1 FGFR1	7.56e-06	200	104	6	05486d86868f6a93429226063cca270f00dd8714
ToppCell	proximal-3-mesenchymal-Adventitial_Fibroblast\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	HIC1 FN1 CPXM2 PDGFRA SPON1 FGFR1	7.56e-06	200	104	6	869d45b71efd395d050873db5fee2ed0443d5e6f
ToppCell	droplet-Liver-hepatocytes-3m-Epithelial-Hepatocyte_(Pericentral_and_Periportal)\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FN1 F2 HSD3B7 ALDH4A1 SLC25A47	2.47e-05	147	104	5	00619115b9a1ec2b967c2992043b41974ece63c4
ToppCell	facs-Marrow-B-cells-24m-Myeloid-promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FN1 CD300A CLEC7A CSF1R OTOGL	3.38e-05	157	104	5	0966e347f8d32b13f8a3b3afba3f64637c69cdf9
ToppCell	facs-Marrow-B-cells-24m-Myeloid-monocyte_+_promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FN1 CD300A CLEC7A CSF1R OTOGL	3.38e-05	157	104	5	6ebfedd91d62c6d4aa8f046657a899a279f82ba2
ToppCell	3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CD300A CLEC7A SFMBT2 CSF1R FCN1	3.70e-05	160	104	5	709ce00699ca05346287868ea55a1affae0859a8
ToppCell	droplet-Liver-Hepatocytes-18m-Epithelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FN1 F2 HSD3B7 ALDH4A1 SLC25A47	3.81e-05	161	104	5	274838cebdc7af1db32d309dfe42ef7ccd3c190b
ToppCell	3'-Distal_airway-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CD300A ESR2 RUNX2 SFMBT2 GZMB	4.04e-05	163	104	5	3087224d3f16f5d3aecc3e1e4366220231afe31f
ToppCell	droplet-Liver-Hepatocytes-18m-Epithelial-hepatocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FN1 F2 HSD3B7 ALDH4A1 SLC25A47	4.04e-05	163	104	5	03d9fa615d9d02ef98e20f28a10aaa6894dd4960
ToppCell	droplet-Liver-Hepatocytes-18m-Epithelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FN1 F2 HSD3B7 ALDH4A1 SLC25A47	4.04e-05	163	104	5	1c4de36cf8cdaabb981cda5c7ce7e5ae7b4280e3
ToppCell	droplet-Liver-Hepatocytes-18m\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FN1 F2 HSD3B7 ALDH4A1 SLC25A47	4.04e-05	163	104	5	7e82c1b7849eca895732df2da74ac6430bd9ba7a
ToppCell	droplet-Spleen-SPLEEN-1m-Hematologic-proerythroblast\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FN1 CD300A CLEC7A CSF1R CTBP2	4.67e-05	168	104	5	f3b7a7df54988de77dcc7066e2fc1feb9c280b13
ToppCell	Tracheal-10x5prime-Immune_Myeloid-Dendritic_cell-DC_plasmacytoid\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ESR2 CHAF1A RUNX2 GZMB C12orf42	4.67e-05	168	104	5	c34dd4a9c54d8e9c8f118e6a3816548890cb0746
ToppCell	droplet-Spleen-nan-21m-Hematologic-proerythroblast\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FN1 CD300A CLEC7A FCGBP CSF1R	4.94e-05	170	104	5	03cb4e508356f85372a588c8d1c6babf2a012683
ToppCell	droplet-Large_Intestine-COLON:P+D-30m-Hematologic-hematopoietic_stem_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HIC1 FN1 CLEC7A CSF1R GZMB	5.36e-05	173	104	5	7456a417c5c1d4ba25f9489065aae322421308a6
ToppCell	droplet-Large_Intestine-COLON:P+D-30m-Hematologic-hematopoietic_stem_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HIC1 FN1 CLEC7A CSF1R GZMB	5.36e-05	173	104	5	35586a9e5f15b41609b6224e33eb3aa3cb7e03b7
ToppCell	droplet-Large_Intestine-COLON:P+D-30m-Hematologic\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HIC1 FN1 CLEC7A CSF1R GZMB	5.36e-05	173	104	5	cd635751f999e12b14c0accfa1c4c1fd3c1d4540
ToppCell	5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRTG PDGFRA RPS6KA2 KCNH1 SPON1	5.51e-05	174	104	5	f90ca117b729436cf452e2ddcec26ba525c5c13b
ToppCell	3'-Parenchyma_lung-Epithelial-Epithelial_transtional-epithelial_cell_of_lung-Transitional_Club-AT2-Transitional_Club-AT2_L.0.4.1.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PRTG TMEM214 FCGBP MDN1 CEP95	5.66e-05	175	104	5	dbd9dac129fb6ae5f55e7b96d04b37585458dc4a
ToppCell	facs-Thymus-Epithelium-3m-Myeloid-macrophage\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CUBN PTAR1 ZSCAN18 SNX9 IL5RA	5.98e-05	177	104	5	c2b8a3a149d70f77612759dea34df9e43953c566
ToppCell	facs-Thymus-Epithelium-3m-Myeloid-macrophage\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CUBN PTAR1 ZSCAN18 SNX9 IL5RA	5.98e-05	177	104	5	384f841aa7b2d05815af7885e481f5affc55d897
ToppCell	droplet-Spleen-nan-24m-Hematologic-proerythroblast\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FN1 CD300A CLEC7A CSF1R CTBP2	5.98e-05	177	104	5	5f20a1a875d6f85ec07b097e6afdb07c2f8f88ff
ToppCell	facs-Thymus-Epithelium-3m-Myeloid\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CUBN PTAR1 ZSCAN18 SNX9 IL5RA	5.98e-05	177	104	5	0e9e44119653abfd270e602e5e477a15e774638f
ToppCell	droplet-Spleen-SPLEEN-30m-Hematologic-proerythroblast\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FN1 CD300A CLEC7A CSF1R CTBP2	6.14e-05	178	104	5	be8af4d85b8835a85a168639c37857dcaa6b00bf
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CD300A CLEC7A SFMBT2 CSF1R FCN1	6.14e-05	178	104	5	aa9f68a66e292f331faef881bbd0d028f0f2b0c5
ToppCell	renal_papilla_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	PRTG ESR2 RUNX2 LINGO1 MKLN1	6.47e-05	180	104	5	49829e833fe6d2431cfd2e8f378c2aaa3b2b46a4
ToppCell	10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-osteoblast\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	PRSS35 PRTG RIPPLY2 RUNX2 SPON1	6.82e-05	182	104	5	193cb2df3d7ea4cb9a11390b92955e7d9b0a053a
ToppCell	droplet-Spleen-nan-24m-Lymphocytic-immature_NKT_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WDR31 CHAF1A CCNE2 NMT2 GZMB	7.18e-05	184	104	5	b998803180322a5ea2b567928dea531c26816c3c
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c3-EREG\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	FN1 DNAJC6 HSD3B7 CSF1R CTBP2	7.37e-05	185	104	5	7bff05d8d34616adbaa0ea0b69eb30aa906bb9f8
ToppCell	moderate-Lymphoid-NK\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	PRSS35 PRTG FN1 CPXM2 PDGFRA	7.37e-05	185	104	5	4979a787acbc9b4ca8defe91cc79b674e51af1bf
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PRSS35 FN1 PDGFRA RUNX1 SPON1	7.75e-05	187	104	5	c104fbfef2d0bef64077ac721edf2379fd59d547
ToppCell	10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-osteochondral_precursor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	FN1 PDGFRA RUNX2 ACOT12 LINGO1	7.95e-05	188	104	5	ed92cddf47defea2f904d36c7ae05ffa323349a9
ToppCell	metastatic_Lymph_Node-Myeloid_cells-CD163+CD14+_DCs\|metastatic_Lymph_Node / Location, Cell class and cell subclass	HIC1 CD300A CLEC7A FCGBP CSF1R	7.95e-05	188	104	5	5d12afb483d028ca02b3b4215131f6128e8bcd48
ToppCell	Mid-temporal_gyrus_(MTG)-Non-neuronal-Endothelial_Myeloid\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CD300A CLEC7A RUNX1 SAMD9L CSF1R	8.15e-05	189	104	5	e9fe8d17f4b7cca9bbf3655047e27b2fec5060c1
ToppCell	COVID-19-Heart-Macrophage\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CLEC7A RUNX1 SFMBT2 FCGBP CSF1R	8.15e-05	189	104	5	2586f4088721c5debec86c2b211b739fd33713eb
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CD300A CLEC7A CSF1R FCN1 C12orf42	8.35e-05	190	104	5	7c402aa47f1bd7decacc366c1ed1a37e39b95c73
ToppCell	Monocytes-Tissue-resident_macrophages\|World / Immune cells in Kidney/Urine in Lupus Nephritis	FN1 RPS6KA2 CLEC7A FCGBP CSF1R	8.35e-05	190	104	5	07215e8f292cb54c670037aaf28393cddbe5548c
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CD300A CLEC7A CSF1R FCN1 C12orf42	8.56e-05	191	104	5	c72e62cf5b45c04ee5e7719db31f917c4f76b1e4
ToppCell	droplet-Heart-HEART-1m-Endothelial-endocardial_endothelial_cells\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FN1 RPS6KA2 FRMPD1 BMX IGSF3	8.56e-05	191	104	5	4bfdf44d4402a42530d30c89d94946acdda4321b
ToppCell	facs-Heart-LA-3m-Endothelial-endothelial_cell_of_endocardium\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FN1 RPS6KA2 BMX SPON1 IGSF3	8.77e-05	192	104	5	14a816ef116aa992f86edab411f043cf7d07fe04
ToppCell	PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	NRIP1 HIC1 FN1 CLEC7A FCN1	8.77e-05	192	104	5	f14ee74ac3275601749a23c5efe39c2413a62e1a
ToppCell	PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	NRIP1 HIC1 FN1 CLEC7A FCN1	8.77e-05	192	104	5	0219093e7921a0db78053aee13ec480b520f5662
ToppCell	facs-Heart-LA-3m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FN1 RPS6KA2 BMX SPON1 IGSF3	8.77e-05	192	104	5	847822514d747a21d5eb40e04ba9a023fd32bd65
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CD300A CLEC7A CSF1R FCN1 CTBP2	8.77e-05	192	104	5	7bcdbd97fa8c3bfccde426d44979601226913fc3
ToppCell	3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CD300A CLEC7A SFMBT2 CSF1R FCN1	8.99e-05	193	104	5	cb0fb21510124883e716780bea46575620c366b8
ToppCell	3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CD300A CLEC7A SFMBT2 CSF1R FCN1	8.99e-05	193	104	5	0c207879f994c227dcd1322faa69ec9e3749cdaa
ToppCell	3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CD300A CLEC7A SFMBT2 CSF1R FCN1	8.99e-05	193	104	5	0fbbfcc803edc3cd96b35467ad5cc573af07fd67
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	NRIP1 CLEC7A CSF1R FCN1 CTBP2	8.99e-05	193	104	5	00c9c2945d2bdaa128e054cf3c59df86a279b659
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Immune\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CD300A CLEC7A SFMBT2 CSF1R C12orf42	9.21e-05	194	104	5	96f16bcd393a0d3f8df479b172b5360ae5a1e663
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CD300A CLEC7A SFMBT2 CSF1R FCN1	9.21e-05	194	104	5	de9c7c602d886d0cd8bbd1d7e7744f84df951238
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CD300A CLEC7A SFMBT2 CSF1R FCN1	9.21e-05	194	104	5	49441ca0a8fa34cb847fecbb4b809dd01d879ebb
ToppCell	medial-Hematologic-Nonclassical_Monocyte\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CD300A CLEC7A SFMBT2 CSF1R FCN1	9.21e-05	194	104	5	ac203d388a3a3884e316dec0dcbd408e43c6ef6c
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CD300A CLEC7A SFMBT2 CSF1R FCN1	9.21e-05	194	104	5	16c6fcbd36d473b883fb5361caca86eb134767ab
ToppCell	distal-Hematologic-Nonclassical_Monocyte-1\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CD300A CLEC7A SFMBT2 CSF1R FCN1	9.21e-05	194	104	5	f1cabb198ab32deaf299899c5e8f42d861b8c574
ToppCell	medial-2-Hematologic-Nonclassical_Monocyte\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CD300A CLEC7A SFMBT2 CSF1R FCN1	9.21e-05	194	104	5	202e5070728191c46161fa7d931f00be1c7559d4
ToppCell	medial-Hematologic-Nonclassical_Monocyte-2\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CD300A CLEC7A SFMBT2 CSF1R FCN1	9.21e-05	194	104	5	002cd317732fc6b0d9a72fb46199f71db5a638a7
ToppCell	droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CPXM2 PDGFRA SPON1 FGFR1 IGSF3	9.21e-05	194	104	5	ca1f24070424b44b7a442e4fca761ebfbe24b063
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CD300A CLEC7A CSF1R FCN1 C12orf42	9.21e-05	194	104	5	badefcec2af86cbcd97305f4843e84db0f3ebc66
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CD300A CLEC7A CSF1R FCN1 CTBP2	9.44e-05	195	104	5	157f1f9b0521c9eba11806eb4b6802ff116ab912
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CD300A CLEC7A SFMBT2 CSF1R C12orf42	9.44e-05	195	104	5	91a3c439f10c03c5d51d904f512b6a08040edc76
ToppCell	distal-Hematologic-Nonclassical_Monocyte\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CD300A CLEC7A SFMBT2 CSF1R FCN1	9.44e-05	195	104	5	6f417bb464b8ae6a50bbab5db5a6d5760c02122f
ToppCell	distal-Hematologic-Nonclassical_Monocyte-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CD300A CLEC7A SFMBT2 CSF1R FCN1	9.44e-05	195	104	5	935461e849ca4d17627341b3ae5124d497793a91
ToppCell	distal-2-Hematologic-Nonclassical_Monocyte\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CD300A CLEC7A SFMBT2 CSF1R FCN1	9.44e-05	195	104	5	34bed73e4dae34b0f1076b7ff9dc7ea2096c1796
ToppCell	wk_20-22-Hematologic-Myeloid-S100A12-lo_cla._mono.\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	CD300A CLEC7A FCGBP CSF1R FCN1	9.44e-05	195	104	5	66273af9882f829b6fc0e20f03f3412294d37c26
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Monocytic-Nonclassical_Monocyte\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CD300A CLEC7A CSF1R FCN1 CTBP2	9.44e-05	195	104	5	95327f2818bcdca53dbd2971f674a9042a1392c6
ToppCell	normal_Lymph_Node-Myeloid_cells-CD1c+_DCs\|normal_Lymph_Node / Location, Cell class and cell subclass	HIC1 CD300A CLEC7A CSF1R FCN1	9.44e-05	195	104	5	cd4d61a463e0e87b711e08ceedee5bef5d735e64
ToppCell	15-Trachea-Mesenchymal\|Trachea / Age, Tissue, Lineage and Cell class	PRSS35 HIC1 FN1 PDGFRA FGFR1	9.67e-05	196	104	5	7e178c76285e61c721c38d7a995ebf89dc428f9f
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PRSS35 HIC1 FN1 PDGFRA SPON1	9.67e-05	196	104	5	525d6c8a277364e624e7cc586275f8a891436b57
ToppCell	Healthy/Control-B_naive\|Healthy/Control / Disease group and Cell class	SEMA4B NSUN7 ZSCAN18 C12orf42 SNX9	9.67e-05	196	104	5	e92d2c814d2dcb049f3e455fe66fd40898b3524d
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Monocytic-Nonclassical_Monocyte\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CD300A CLEC7A CSF1R FCN1 CTBP2	9.67e-05	196	104	5	29246378ffb1010fe6858da756ae3d13df2306ba
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Nonclassical_Monocyte\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	HIC1 CLEC7A CSF1R FCN1 CTBP2	9.67e-05	196	104	5	84c7f2153b5a9c4da7ae48fdf816a163c33d9a5e
ToppCell	PND10-Mesenchymal\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PRSS35 FN1 PDGFRA SPON1 FGFR1	9.67e-05	196	104	5	ace167a40adb7022b365be3c2b1cbd4ba963739a
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	CD300A CLEC7A CSF1R FCN1 CTBP2	9.67e-05	196	104	5	51fc8bb9a806f8fbf78d5d80d535f1068a9770c2
ToppCell	3'_v3-Lung-Myeloid_Monocytic-Nonclassical_monocytes\|Lung / Manually curated celltypes from each tissue	CD300A CLEC7A SFMBT2 CSF1R FCN1	9.67e-05	196	104	5	7fe97109a5a06b35fc081a85f341ea78da131323
ToppCell	5'-Adult-SmallIntestine-Hematopoietic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CD300A CLEC7A RUNX2 SFMBT2 CSF1R	9.67e-05	196	104	5	008e7593ab26988b957673f863bdd017516281ae
ToppCell	PND07-Mesenchymal\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PRSS35 FN1 PDGFRA SPON1 FGFR1	9.67e-05	196	104	5	0050c7134473fbfd7b9f0ae8d6d337713e60b57d
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_dendritic\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	CD300A CLEC7A CSF1R FCN1 RAC1	9.90e-05	197	104	5	e2c53742c7d8d1b63d93843f82330b9e20f1faa6
ToppCell	ILEUM-inflamed-(3)_MNP\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	CD300A CLEC7A CSF1R FCN1 RAC1	9.90e-05	197	104	5	b105bad5ac85961919a654a38587d1017973c981
ToppCell	10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	PRTG FN1 PDGFRA RUNX2 FGFR1	9.90e-05	197	104	5	2f72fd9a5b6d62c24a95ed2246194ea7458c0f12
ToppCell	wk_15-18-Hematologic-Myeloid-S100A12-lo_cla._mono.\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	CD300A CLEC7A FCGBP CSF1R FCN1	9.90e-05	197	104	5	5bf4d964a9ee82002d3bc9ba1f020902eb96de7a
ToppCell	facs-Heart-LA-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FN1 PDGFRA SPON1 FGFR1 IGSF3	9.90e-05	197	104	5	2a91738cb6d7588869dd00deeea0cbbc2d6aa34d
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CD300A CLEC7A SFMBT2 CSF1R FCN1	9.90e-05	197	104	5	c6e977adb1248957d31300312310e08238b64236
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CD300A CLEC7A RUNX2 CSF1R FCN1	9.90e-05	197	104	5	72cd61b868d57862ec9c230ea68913d3829b0f2b
ToppCell	COVID-19-lung-Macrophage_VCANhi_FCN1hi\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CD300A CLEC7A RUNX1 CSF1R FCN1	1.01e-04	198	104	5	ea34096bee852a7e996f097fa279381afa8f86ff
ToppCell	medial-Hematologic-Intermediate_Monocyte\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CD300A CLEC7A SFMBT2 CSF1R FCN1	1.01e-04	198	104	5	dbd7869483c5a67944cb94ced0ee2c7b999adc2e
ToppCell	medial-Hematologic-Intermediate_Monocyte-2\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CD300A CLEC7A SFMBT2 CSF1R FCN1	1.01e-04	198	104	5	8f64bb5cd8c3e2d5ef651821b0d59f67d1ca1a12
Drug	bz-Ar	FN1 FNDC3A F2	3.11e-06	7	103	3	CID000137302
Drug	LY294002; Up 200; 10uM; ssMCF7; HG-U133A	FN1 ABHD18 CD300A ESR2 RUNX2 RUNX1 SPON1 IL5RA	3.21e-06	197	103	8	401_UP
Drug	HepIII	FN1 FNDC3A RUNX2 FGFR1	6.40e-06	27	103	4	CID003036270
Drug	CP094	CARM1 TMPRSS15 FN1 FNDC3A CUBN PFKM RAC1	1.02e-05	165	103	7	CID000086322
Disease	calcium oxalate nephrolithiasis (biomarker_via_orthology)	FN1 F2	3.34e-05	3	99	2	DOID:0080652 (biomarker_via_orthology)
Disease	Eosinophilic esophagitis	CAPN14 TNK2	6.66e-05	4	99	2	C0341106
Disease	renal cell carcinoma (is_marker_for)	FN1 PDGFRA CSF1R KCNH1 FGFR1	7.33e-05	128	99	5	DOID:4450 (is_marker_for)
Disease	erythrocyte aggregation	SFMBT2 C12orf42	1.66e-04	6	99	2	EFO_0803375
Disease	protein S measurement	DNAJC6 LINGO1	2.31e-04	7	99	2	EFO_0004637
Disease	Malignant neoplasm of breast	NRIP1 HIC1 FN1 ESR2 FRMPD1 CUBN CSF1R OTOGL KCNH1 GZMB NLE1 FGFR1	2.55e-04	1074	99	12	C0006142
Disease	Mammary Carcinoma, Human	NRIP1 HIC1 FN1 ESR2 CSF1R KCNH1 GZMB FGFR1	3.96e-04	525	99	8	C4704874
Disease	Mammary Neoplasms, Human	NRIP1 HIC1 FN1 ESR2 CSF1R KCNH1 GZMB FGFR1	3.96e-04	525	99	8	C1257931
Disease	Mammary Neoplasms	NRIP1 HIC1 FN1 ESR2 CSF1R KCNH1 GZMB FGFR1	4.06e-04	527	99	8	C1458155
Disease	Childhood Medulloblastoma	HIC1 PDGFRA ESR2	4.10e-04	43	99	3	C0278510
Disease	Melanotic medulloblastoma	HIC1 PDGFRA ESR2	4.10e-04	43	99	3	C1275668
Disease	Medullomyoblastoma	HIC1 PDGFRA ESR2	4.10e-04	43	99	3	C0205833
Disease	Desmoplastic Medulloblastoma	HIC1 PDGFRA ESR2	4.10e-04	43	99	3	C0751291
Disease	Adult Medulloblastoma	HIC1 PDGFRA ESR2	4.10e-04	43	99	3	C0278876
Disease	hip geometry	RUNX2 RUNX1 OTOGL	4.39e-04	44	99	3	EFO_0004685
Disease	Breast Carcinoma	NRIP1 HIC1 FN1 ESR2 CSF1R KCNH1 GZMB FGFR1	4.65e-04	538	99	8	C0678222
Disease	Holoprosencephaly sequence	FGFR1 FOXH1	4.93e-04	10	99	2	cv:C0079541
Disease	Medulloblastoma	HIC1 PDGFRA ESR2	6.40e-04	50	99	3	C0025149
Disease	myeloid leukemia (is_implicated_in)	PDGFRA FGFR1	8.48e-04	13	99	2	DOID:8692 (is_implicated_in)
Disease	iron deficiency anemia (biomarker_via_orthology)	SLC11A2 FN1	8.48e-04	13	99	2	DOID:11758 (biomarker_via_orthology)
Disease	hip bone mineral density	FCN1 KCNH1 SPON1 NMT2	8.72e-04	126	99	4	EFO_0007702
Disease	age at menarche	NEMP1 MYO1H FNDC3A DNAJC6 BCDIN3D LINGO1 RTL1 CTBP2	8.85e-04	594	99	8	EFO_0004703
Disease	systemic lupus erythematosus (is_implicated_in)	ESR2 CHAF1A F2	1.20e-03	62	99	3	DOID:9074 (is_implicated_in)
Disease	APOE carrier status, dementia	GALR1 RPS6KA2 MKLN1	1.20e-03	62	99	3	EFO_0007659, MONDO_0001627
Disease	Cocaine Dependence	GPHN GALR1 ESR2 RUNX2	1.26e-03	139	99	4	C0600427
Disease	Lobar Holoprosencephaly	FGFR1 FOXH1	1.30e-03	16	99	2	C0431362
Disease	Semilobar Holoprosencephaly	FGFR1 FOXH1	1.30e-03	16	99	2	C0751617
Disease	Alcohol abuse	GPHN FN1 F2	1.50e-03	67	99	3	C0085762
Disease	glomerulonephritis (is_marker_for)	FN1 F2	1.84e-03	19	99	2	DOID:2921 (is_marker_for)
Disease	Craniofacial Abnormalities	MBTPS1 PDGFRA RUNX2 FGFR1	1.92e-03	156	99	4	C0376634
Disease	asthma, endometriosis	FN1 RUNX1 TMPRSS7	2.00e-03	74	99	3	EFO_0001065, MONDO_0004979
Disease	Craniosynostosis	RUNX2 FGFR1	2.04e-03	20	99	2	C0010278
Disease	Parkinson's disease (is_implicated_in)	SLC11A2 ESR2 DNAJC6	2.16e-03	76	99	3	DOID:14330 (is_implicated_in)
Disease	Precursor B-cell lymphoblastic leukemia	PDGFRA RUNX1	2.24e-03	21	99	2	C1292769
Disease	disease of metabolism (implicated_via_orthology)	PFKM ALDH4A1	2.24e-03	21	99	2	DOID:0014667 (implicated_via_orthology)
Disease	in situ carcinoma (is_marker_for)	PDGFRA ESR2	2.24e-03	21	99	2	DOID:8719 (is_marker_for)
Disease	Glioblastoma	FN1 PDGFRA RUNX1	2.41e-03	79	99	3	C0017636
Disease	anthropometric measurement	FN1 MYO1H RUNX2 RUNX1	2.51e-03	168	99	4	EFO_0004302
Disease	Giant Cell Glioblastoma	FN1 RUNX1 FGFR1	2.87e-03	84	99	3	C0334588
Disease	HDL cholesterol change measurement	ESR2 FNDC3A	2.93e-03	24	99	2	EFO_0007805
Disease	Cerebral Astrocytoma	ESR2 FGFR1	3.18e-03	25	99	2	C0750935
Disease	Intracranial Astrocytoma	ESR2 FGFR1	3.18e-03	25	99	2	C0750936
Disease	pre-eclampsia (is_implicated_in)	ESR2 F2	3.18e-03	25	99	2	DOID:10591 (is_implicated_in)
Disease	Astrocytoma	ESR2 FGFR1	3.18e-03	25	99	2	C0004114
Disease	Grade I Astrocytoma	ESR2 FGFR1	3.18e-03	25	99	2	C1704230
Disease	Subependymal Giant Cell Astrocytoma	ESR2 FGFR1	3.18e-03	25	99	2	C0205768
Disease	Mixed oligoastrocytoma	ESR2 FGFR1	3.18e-03	25	99	2	C0547065
Disease	Pilocytic Astrocytoma	ESR2 FGFR1	3.18e-03	25	99	2	C0334583
Disease	Juvenile Pilocytic Astrocytoma	ESR2 FGFR1	3.18e-03	25	99	2	C0280783
Disease	Diffuse Astrocytoma	ESR2 FGFR1	3.18e-03	25	99	2	C0280785
Disease	Childhood Cerebral Astrocytoma	ESR2 FGFR1	3.18e-03	25	99	2	C0338070
Disease	FEV change measurement, response to zileuton	PRSS35 CHRNA2	3.18e-03	25	99	2	EFO_0005921, EFO_0007676

Protein segments in the cluster

Peptide	Gene	Start	Entry
KDAPNLICTPHTAWY	CTBP2	311	P56545
RHPYPCSKALAEWLV	HSD3B7	156	Q9H2F3
YSCWHELPEKRPTFQ	BMX	646	P51813
LSSLCHYLLVEPQPW	BCDIN3D	186	Q7Z5W3
PPRACTKVSSFVHWI	GZMB	226	P10144
FIVPKEWNSKYRPVC	ABHD18	96	Q0P651
VTKKHQYEIRNCWPP	CCNE2	46	O96020
VHWVPPAIYKSSCSI	CHRNA2	171	Q15822
TKRPLWDPHFVSCEV	ACOT12	411	Q8WYK0
CSRLYVPHSLWPQIK	ALDH4A1	351	P30038
EHLPVPCQWSYVTSV	CHAF1A	831	Q13111
FRIHTPPAKANCVAW	ACTR10	341	Q9NZ32
QCWAHKPEDRPTFVA	TNK2	366	Q07912
CKHRPEYLVKLRNPW	CAPN14	266	A8MX76
PYDLVRSPWKTQEHT	CPXM2	526	Q8N436
CLEEWTSPVHQKIYT	QRFPR	201	Q96P65
KWYPEVRHHCPNTPI	RAC1	96	P63000
KLDPRPEYHRCILTW	GPHN	666	Q9NQX3
LHGLIQVPCSPWKQY	RDM1	246	Q8NG50
HQRTEECYLPSWLTP	OVOS1	376	Q6IE37
KCWNSEPEKRPSFYH	PDGFRA	931	P16234
VKHPPSVKYAWCFLS	FAM86B2	61	P0C5J1
RSLWYQQTLPPHEAK	MDN1	3636	Q9NU22
PPIYCKSDDRTRVNW	MAEL	211	Q96JY0
SHLYAEPQKSPWCEA	ESR2	96	Q92731
PNKSIYDVWVSHPRD	FOXH1	336	O75593
KPIATCRYWHRSLNP	NMT2	291	O60551
TPPRSKRVLWDQYHN	MBTPS1	616	Q14703
EKTHWLTRPYPCTIC	HIC1	526	Q14526
WRIQCVPKEPHSFQS	MYG1	301	Q9HB07
THYPKPSETSVVCQW	TMPRSS15	241	P98073
RTYCRWKSKSPSPVH	MCM3AP	1716	O60318
TAPTEPLTHWYQVRC	CARM1	406	Q86X55
WPVRKIPLRCTAHYV	CPSF1	1011	Q10570
VKHPPSVKYAWCFLS	FAM86B1	61	Q8N7N1
NWEVYKLLAHVRPPV	PFKM	381	P08237
EHPIQWLYITCRKVC	NEMP1	316	O14524
WIYRQLCETSTPLHP	INTS2	576	Q9H0H0
PPHIILHYCVFKTTW	KCNH1	206	O95259
SCQPKPIHYDTENWT	MYCLP1	261	P12525
HSLVIKWNSPPYVCS	NRIP1	571	P48552
ISHWPYLDTMTPNCL	LINGO1	246	Q96FE5
VCHRQYPKVPRVILW	SLC11A2	136	P49281
NWIQHYLCDAPPILK	OR10G8	171	Q8NGN5
LSTTEMYLCRWHQPP	MSL1	426	Q68DK7
TFDPHFLRVPCWKIT	MOG	196	Q16653
GRIRCHQYWPEDNKP	PTPRQ	2141	Q9UMZ3
CKISSHPPAVITWEF	PRTG	156	Q2VWP7
WHTIYLPDCRPLTVL	FCN1	131	O00602
SLCKWYQPIPVHLLQ	MALRD1	1096	Q5VYJ5
YPGERTCRWTIHQPQ	CUBN	836	O60494
YWLRTHPNCIVGKEL	PIKFYVE	376	Q9Y2I7
WPDPRHKKAYVVCTF	GALR1	191	P47211
AIHLYVKDPARPWNV	CSF1R	96	P07333
SFDLQCIIKPHYPAW	IGSF3	561	O75054
LLWIKEPHLNYSPTC	IGSF3	1166	O75054
IQWEKPVSAFPIHCF	IL5RA	256	Q01344
CWHAVPSQRPTFKQL	FGFR1	736	P11362
VAVKPWRTDSFCPLH	FCGBP	5106	Q9Y6R7
NAPQPSHISKYILRW	FN1	631	P02751
APLSRKSHIWPEYCS	FRMPD1	1391	Q5SYB0
HYSPSTCLAISWEKP	FNDC3A	871	Q9Y2H6
PPWEHYCTKDVNPSI	DNAJC6	376	O75061
AHKLAKRCYTNPPQW	DENND4C	756	Q5VZ89
TPECSQPWKIYSRKT	CEP95	526	Q96GE4
NHPYTEKPRLWHTAC	KLHDC2	311	Q9Y2U9
FLHRCSWLVPSPKVY	HSDL1	261	Q3SXM5
DKWLSYPETQHVPLS	CYP20A1	151	Q6UW02
SPHNTLYLELWCPTV	CFAP74	1221	Q9C0B2
LEPRYTVWVHNSPKC	OTOGL	156	Q3ZCN5
PTHWRCNKTLPIAFK	RUNX1	76	Q01196
LPSHWRCNKTLPVAF	RUNX2	126	Q13950
PVWLYTEPLVCIHQN	RTL1	471	A6NKG5
SWEPLHANPECRYVA	NLE1	206	Q9NVX2
VTVSHRPQPYRWSCE	RNF135	281	Q8IUD6
QEHWKRCTGPLPKEY	SNX9	421	Q9Y5X1
PKDYPRRANHWSAII	SPON1	221	Q9HCB6
VESWCVKFLLPYVHN	PTAR1	56	Q7Z6K3
PECRLLPYALHKWSS	MKLN1	11	Q9UL63
CTIYVAKNYPPWQHT	LARS1	936	Q9P2J5
SETYKPLEPHLWQRE	SAMD9L	506	Q8IVG5
PTQHLYCRWVAPKAL	NSUN7	671	Q8NE18
PDKQQPWVYVRCGHV	PELI3	351	Q8N2H9
KHVSLYQPQLATRPW	SEMA4B	551	Q9NPR2
RIQTEPKYTGIWHCV	SLC25A47	26	Q6Q0C1
EHRTLNKYWCRPPQI	CD300A	41	Q9UGN4
PSPNCVWIHVSVIYD	CLEC7A	216	Q9BXN2
WDRSTPSAKHIPCYE	C12orf42	41	Q96LP6
AYRSHPDNAIPIKSW	CTDNEP1	191	O95476
NSVPVPRHWCFKRKY	SF3B2	496	Q13435
CLTDHFKPLWARNVP	UFC1	116	Q9Y3C8
TRVSNFVPWIHKYVP	TMPRSS7	826	Q7RTY8
ITPLKYAQICLWIHG	PRSS35	391	Q8N3Z0
RHPVRLFWPKSKCYD	RIPPLY2	76	Q5TAB7
YICAEPLPSNILEWH	UBE2J2	31	Q8N2K1
WCEANSYPLTAPHKT	SFMBT2	466	Q5VUG0
DPLSASVWRQLYPKH	TMEM214	396	Q6NUQ4
IPRSHCWVYDPLFSQ	SRRD	171	Q9UH36
RPWVVAQYPESCKKA	ZSCAN18	106	Q8TBC5
RAIELWYHDPACTTP	XPO7	756	Q9UIA9
LWRSRYPHKPEINST	F2	131	P00734
VLTAAHCLLYPPWDK	F2	401	P00734
VTHLCWVPREPYILQ	WDR31	191	Q8NA23
AKPPVVCSHFAQDLW	ZNF486	81	Q96H40
QLPQWLPTHSKRTYD	ZMAT1	376	Q5H9K5
VLKHPWVVNREYLSP	RPS6KA2	666	Q15349
FLQRYKSLCPDTWPH	MYO1H	641	Q8N1T3